Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 147362, 14 pages
http://dx.doi.org/10.1155/2013/147362
Research Article

A Systematic, Integrated Study on the Neuroprotective Effects of Hydroxysafflor Yellow A Revealed by NMR-Based Metabonomics and the NF- B Pathway

1State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
2School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102, China

Received 5 February 2013; Accepted 2 March 2013

Academic Editor: Aiping Lu

Copyright © 2013 Yuanyan Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Hachinski, C. Iadecola, R. C. Petersen et al., “National institute of neurological disorders and stroke-Canadian stroke network vascular cognitive impairment harmonization standards,” Stroke, vol. 37, no. 9, pp. 2220–2241, 2007. View at Google Scholar
  2. K. Kazuma, T. Takahashi, K. Sato, H. Takeuchi, T. Matsumoto, and T. Okuno, “Quinochalcones and flavonoids from fresh florets in different cultivars of Carthamus tinctorius L.,” Bioscience, Biotechnology and Biochemistry, vol. 64, no. 8, pp. 1588–1599, 2000. View at Google Scholar · View at Scopus
  3. B. X. Zang, M. Jin, N. Si, Y. Zhang, W. Wu, and Y. Z. Piao, “Antagonistic effect of hydroxysafflor yellow a on the platelet activating factor receptor,” Yao Xue Xue Bao, vol. 37, no. 9, pp. 696–699, 2002. View at Google Scholar · View at Scopus
  4. J. Tian, W. Jang, Z. Wang, C. Wang, and F. Fu, “Effects of safflower flavone on local cerebral ischemia and thrombosis formation in rats,” Chinese Traditional and Herbal Drugs, vol. 34, pp. 741–743, 2003. View at Google Scholar
  5. H. Zhu, Z. Wang, C. Ma et al., “Neuroprotective effects of hydroxysafflor yellow a: in vivo and in vitro studies,” Planta Medica, vol. 69, no. 5, pp. 429–433, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. X. Wei, H. Liu, X. Sun et al., “Hydroxysafflor yellow A protects rat brains against ischemia-reperfusion injury by antioxidant action,” Neuroscience Letters, vol. 386, no. 1, pp. 58–62, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. Z. Liu, C. Li, M. Li, D. Li, and K. Liu, “The subchronic toxicity of hydroxysafflor yellow A of 90 days repeatedly intraperitoneal injections in rats,” Toxicology, vol. 203, no. 1–3, pp. 139–143, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Nurmi, P. J. Lindsberg, M. Koistinaho et al., “Nuclear factor-κB contributes to infarction after permanent focal ischemia,” Stroke, vol. 35, no. 4, pp. 987–991, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. J. C. Lindon, E. Holmes, and J. K. Nicholson, “Metabonomics techniques and applications to pharmaceutical research & development,” Pharmaceutical Research, vol. 23, no. 6, pp. 1075–1088, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. M. P. Mattson, “NF-κB in the survival and plasticity of neurons,” Neurochemical Research, vol. 30, no. 6-7, pp. 883–893, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. M. A. Collart, P. Baeuerle, and P. Vassalli, “Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four κB-like motifs and of constitutive and inducible forms of NF-κB,” Molecular and Cellular Biology, vol. 10, no. 4, pp. 1498–1506, 1990. View at Google Scholar · View at Scopus
  12. Z. Yu, D. Zhou, A. J. Bruce-Keller, M. S. Kindy, and M. P. Mattson, “Lack of the p50 subunit of nuclear factor-κb increases the vulnerability of hippocampal neurons to excitotoxic injury,” Journal of Neuroscience, vol. 19, no. 20, pp. 8856–8865, 1999. View at Google Scholar · View at Scopus
  13. J. C. Lindon and J. K. Nicholson, “Analytical technologies for metabonomics and metabolomics, and multi-omic information recovery,” TrAC—Trends in Analytical Chemistry, vol. 27, no. 3, pp. 194–204, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Holmes, R. L. Loo, J. Stamler et al., “Human metabolic phenotype diversity and its association with diet and blood pressure,” Nature, vol. 453, no. 7193, pp. 396–400, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. J. K. Nicholson, J. C. Lindon, and E. Holmes, “‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data,” Xenobiotica, vol. 29, no. 11, pp. 1181–1189, 1999. View at Google Scholar · View at Scopus
  16. E. Z. Longa, P. R. Weinstein, S. Carlson, and R. Cummins, “Reversible middle cerebral artery occlusion without craniectomy in rats,” Stroke, vol. 20, no. 1, pp. 84–91, 1989. View at Google Scholar · View at Scopus
  17. H. W. L. Ziegler-Heitbrock, T. Sternsdorf, J. Liese et al., “Pyrrolidine dithiocarbamate inhibits NF-κB mobilization and TNF production in human monocytes,” Journal of Immunology, vol. 151, no. 12, pp. 6986–6993, 1993. View at Google Scholar · View at Scopus
  18. C. L. Gavaghan, I. D. Wilson, and J. K. Nicholson, “Physiological variation in metabolic phenotyping and functional genomic studies: use of orthogonal signal correction and PLS-DA,” FEBS Letters, vol. 530, no. 1–3, pp. 191–196, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Z. Kong, Y. F. Xian, S. P. Ip et al., “Protective effects of hydroxysafflor yellow A on β-amyloid-induced neurotoxicity in PC12 cells,” Neurochemical Research, 2013. View at Publisher · View at Google Scholar
  20. H. Seegers, E. Grillon, Y. Trioullier, A. Väth, J. M. Verna, and D. Blum, “Nuclear factor-κB activation in permanent intraluminal focal cerebral ischemia in the rat,” Neuroscience Letters, vol. 288, no. 3, pp. 241–245, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Li, Z. Y. Zhang, and J. I. Zhang, “Determination of hydroxysafflor yellow A in rat plasma and tissues by high-performance liquid chromatography after oral administration of safflower extract or safflor yellow,” Biomedical Chromatography, vol. 21, no. 3, pp. 326–334, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. Z. Yu, X. Gao, Y. Zhao, and K. Bi, “HPLC determination of safflor yellow A and three active isoflavones from TCM Naodesheng in rat plasma and tissues and its application to pharmacokinetic studies,” Biomedical Chromatography, vol. 21, no. 6, pp. 577–584, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. B. R. S. Broughton, D. C. Reutens, and C. G. Sobey, “Apoptotic mechanisms after cerebral ischemia,” Stroke, vol. 40, no. 5, pp. e331–e339, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. L. B. Gladden, “Lactate metabolism: a new paradigm for the third millennium,” The Journal of Physiology, vol. 558, no. 1, pp. 5–30, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Zhang, S. Halouska, C. E. Schiaffo, M. R. Sadykov, G. A. Somerville, and R. Powers, “NMR analysis of a stress response metabolic signaling network,” Journal of Proteome Research, vol. 10, no. 8, pp. 3743–3754, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. J. L. Griffin and R. A. Kauppinen, “A metabolomics perspective of human brain tumours,” FEBS Journal, vol. 274, no. 5, pp. 1132–1139, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Ohta, R. Graf, G. Rosner, and W. D. Heiss, “Calcium ion transients in peri-infarct depolarizations may deteriorate ion homeostasis and expand infarction in focal cerebral ischemia in cats,” Stroke, vol. 32, no. 2, pp. 535–543, 2001. View at Google Scholar · View at Scopus
  28. G. Mies, T. Iijima, and K. A. Hossmann, “Correlation between peri-infarct DC shifts and ischaemic neuronal damage in rat,” NeuroReport, vol. 4, no. 6, pp. 709–711, 1993. View at Google Scholar · View at Scopus
  29. S. L. Budd, “Mechanisms of neuronal damage in brain hypoxia/ischemia: focus on the role of mitochondrial calcium accumulation,” Pharmacology and Therapeutics, vol. 80, no. 2, pp. 203–229, 1998. View at Publisher · View at Google Scholar · View at Scopus
  30. R. G. Giffard and R. A. Swanson, “Ischemia-induced programmed cell death in astrocytes,” Glia, vol. 50, no. 4, pp. 299–306, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Mori, N. Tateishi, Y. Kagamiishi et al., “Attenuation of a delayed increase in the extracellular glutamate level in the peri-infarct area following focal cerebral ischemia by a novel agent ONO-2506,” Neurochemistry International, vol. 45, no. 2-3, pp. 381–387, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. T. M. Bliss, M. Ip, E. Cheng et al., “Dual-gene, dual-cell type therapy against an excitotoxic insult by bolstering neuroenergetics,” Journal of Neuroscience, vol. 24, no. 27, pp. 6202–6208, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. T. K. McIntosh, M. Juhler, and T. Wieloch, “Novel pharmacologic strategies in the treatment of experimental traumatic brain injury: 1998,” Journal of Neurotrauma, vol. 15, no. 10, pp. 731–769, 1998. View at Google Scholar · View at Scopus
  34. S. L. Mehta, N. Manhas, and R. Raghubir, “Molecular targets in cerebral ischemia for developing novel therapeutics,” Brain Research Reviews, vol. 54, no. 1, pp. 34–66, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. Z. J. Yang, Y. Xie, G. M. Bosco, C. Chen, and E. M. Camporesi, “Hyperbaric oxygenation alleviates MCAO-induced brain injury and reduces hydroxyl radical formation and glutamate release,” European Journal of Applied Physiology, vol. 108, no. 3, pp. 513–522, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Ye, S. Jalini, L. Zhang, M. Charlton, and P. L. Carlen, “Early ischemia enhances action potential-dependent, spontaneous glutamatergic responses in CA1 neurons,” Journal of Cerebral Blood Flow and Metabolism, vol. 30, no. 3, pp. 555–565, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Zhou, Y. Li, G. Yan et al., “Protective role of taurine against morphine-induced neurotoxicity in C6 cells via inhibition of oxidative stress,” Neurotoxicity Research, vol. 20, no. 4, pp. 334–342, 2011. View at Publisher · View at Google Scholar
  38. F. Lang, J. Madlung, D. Siemen, C. Ellory, A. Lepple-Wienhues, and E. Gulbins, “The involvement of caspases in the CD95(Fas/Apo-1)-but not swelling-induced cellular taurine release from Jurkat T-lymphocytes,” Pflugers Archiv European The Journal of Physiology, vol. 440, no. 1, pp. 93–99, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. M. B. Friis, C. R. Friborg, L. Schneider et al., “Cell shrinkage as a signal to apoptosis in NIH 3T3 fibroblasts,” The Journal of Physiology, vol. 567, no. 2, pp. 427–443, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Gómez-Angelats and J. A. Cidlowski, “Invited review: cell volume control and signal transduction in apoptosis,” Toxicologic Pathology, vol. 30, no. 5, pp. 541–551, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Sá Santos, U. Sonnewald, M. J. T. Carrondo, and P. M. Alves, “The role of glia in neuronal recovery following anoxia: in vitro evidence of neuronal adaptation,” Neurochemistry International, vol. 58, no. 6, pp. 665–675, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. L. L. Sternau, W. D. Lust, A. J. Ricci, and R. Ratcheson, “Role for γ-aminobutyric acid in selective vulnerability in gerbils,” Stroke, vol. 20, no. 2, pp. 281–287, 1989. View at Google Scholar · View at Scopus
  43. A. Pitkanen, P. J. Riekkinen, T. Halonen, A. Ylinen, T. Ruutiainen, and M. Lehtinen, “Amino acid levels in human CSF after generalized seizure,” Journal of Neural Transmission, vol. 70, no. 3-4, pp. 313–319, 1987. View at Google Scholar · View at Scopus
  44. D. A. I. Nita, V. Nita, S. Spulber et al., “Oxidative damage following cerebral ischemia depends on reperfusion—a biochemical study in rat,” Journal of Cellular and Molecular Medicine, vol. 5, no. 2, pp. 163–170, 2001. View at Google Scholar · View at Scopus
  45. P. H. Chan, “Reactive oxygen radicals in signaling and damage in the ischemic brain,” Journal of Cerebral Blood Flow and Metabolism, vol. 21, no. 1, pp. 2–14, 2001. View at Google Scholar · View at Scopus
  46. C. Guidi, L. Potenza, P. Sestili et al., “Differential effect of creatine on oxidatively-injured mitochondrial and nuclear DNA,” Biochimica et Biophysica Acta, vol. 1780, no. 1, pp. 16–26, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. X. Zhang, H. Liu, J. Wu, X. Zhang, M. Liu, and Y. Wang, “Metabonomic alterations in hippocampus, temporal and prefrontal cortex with age in rats,” Neurochemistry International, vol. 54, no. 8, pp. 481–487, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. M. J. Lan, G. A. McLoughlin, J. L. Griffin et al., “Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder,” Molecular Psychiatry, vol. 14, no. 3, pp. 269–279, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. W. Huang, H. Wang, R. Kekuda et al., “Transport of N-acetylaspartate by the Na+-dependent high-affinity dicarboxylate transporter NaDC3 and its relevance to the expression of the transporter in the brain,” Journal of Pharmacology and Experimental Therapeutics, vol. 295, no. 1, pp. 392–403, 2000. View at Google Scholar · View at Scopus
  50. M. A. Jalil, L. Begumi, L. Contreras et al., “Reduced N-acetylaspartate levels in mice lacking aralar, a brain- and muscle-type mitochondrial aspartate-glutamate carrier,” The Journal of Biological Chemistry, vol. 280, no. 35, pp. 31333–31339, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. C. Demougeot, C. Marie, M. Giroud, and A. Beley, “N-acetylaspartate: a literature review of animal research on brain ischaemia,” Journal of Neurochemistry, vol. 90, no. 4, pp. 776–783, 2004. View at Publisher · View at Google Scholar · View at Scopus
  52. J. R. Moffett, B. Ross, P. Arun, C. N. Madhavarao, and A. M. A. Namboodiri, “N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology,” Progress in Neurobiology, vol. 81, no. 2, pp. 89–131, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. M. R. Pears, J. D. Cooper, H. M. Mitchison, R. J. Mortishire-Smith, D. A. Pearce, and J. L. Griffin, “High resolution 1H NMR-based metabolomics indicates a neurotransmitter cycling deficit in cerebral tissue from a mouse model of batten disease,” The Journal of Biological Chemistry, vol. 280, no. 52, pp. 42508–42514, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. J. M. Wardlaw, I. Marshall, J. Wild, M. S. Dennis, J. Cannon, and S. C. Lewis, “Studies of acute ischemic stroke with proton magnetic resonance spectroscopy: relation between time from onset, neurological deficit, metabolite abnormalities in the infarct, blood flow, and clinical outcome,” Stroke, vol. 29, no. 8, pp. 1618–1624, 1998. View at Google Scholar · View at Scopus
  55. R. Senaratne, A. M. Milne, G. M. MacQueen, and G. B. C. Hall, “Increased choline-containing compounds in the orbitofrontal cortex and hippocampus in euthymic patients with bipolar disorder: a proton magnetic resonance spectroscopy study,” Psychiatry Research—Neuroimaging, vol. 172, no. 3, pp. 205–209, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Schneider, A. Martin-Villalba, F. Weih, J. Vogel, T. Wirth, and M. Schwaninger, “NF-κB is activated and promotes cell death in focal, cerebral ischemia,” Nature Medicine, vol. 5, no. 5, pp. 554–559, 1999. View at Publisher · View at Google Scholar · View at Scopus
  57. N. J. Mulcahy, J. Ross, N. J. Rothwell, and S. A. Loddick, “Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat,” The British Journal of Pharmacology, vol. 140, no. 3, pp. 471–476, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. J. M. Lee, M. C. Grabb, G. J. Zipfel, and D. W. Choi, “Brain tissue responses to ischemia,” Journal of Clinical Investigation, vol. 106, no. 6, pp. 723–731, 2000. View at Google Scholar · View at Scopus
  59. U. Dirnagl, C. Iadecola, and M. A. Moskowitz, “Pathobiology of ischaemic stroke: an integrated view,” Trends in Neurosciences, vol. 22, no. 9, pp. 391–397, 1999. View at Publisher · View at Google Scholar · View at Scopus
  60. D. A. Ridder and M. Schwaninger, “NF-κB signaling in cerebral ischemia,” Neuroscience, vol. 158, no. 3, pp. 995–1006, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. E. Candelario-Jalil, Y. Yang, and G. A. Rosenberg, “Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia,” Neuroscience, vol. 158, no. 3, pp. 983–994, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. T. Ueno, Y. Sawa, S. Kitagawa-Sakakida et al., “Nuclear factor-κB decoy attenuates neuronal damage after global brain ischemia: a future strategy for brain protection during circulatory arrest,” Journal of Thoracic and Cardiovascular Surgery, vol. 122, no. 4, pp. 720–727, 2001. View at Publisher · View at Google Scholar · View at Scopus
  63. Q. H. Zhai, N. Futrell, and F. J. Chen, “Gene expression of IL-10 in relationship to TNF-α, IL-1β and IL-2 in the rat brain following middle cerebral artery occlusion,” Journal of the Neurological Sciences, vol. 152, no. 2, pp. 119–124, 1997. View at Publisher · View at Google Scholar · View at Scopus
  64. H. Uno, T. Matsuyama, H. Akita, H. Nishimura, and M. Sugita, “Induction of tumor necrosis factor-α in the mouse hippocampus following transient forebrain ischemia,” Journal of Cerebral Blood Flow and Metabolism, vol. 17, no. 5, pp. 491–499, 1997. View at Google Scholar · View at Scopus
  65. S. D. Lavine, F. M. Hofman, and B. V. Zlokovic, “Circulating antibody against tumor necrosis factor-α protects rat brain from reperfusion injury,” Journal of Cerebral Blood Flow and Metabolism, vol. 18, no. 1, pp. 52–58, 1998. View at Google Scholar · View at Scopus
  66. F. C. Barone, B. Arvin, R. F. White et al., “Tumor necrosis factor-α: a mediator of focal ischemic brain injury,” Stroke, vol. 28, no. 6, pp. 1233–1244, 1997. View at Google Scholar · View at Scopus
  67. H. Ooboshi, S. Ibayashi, T. Shichita et al., “Postischemic gene transfer of interleukin-10 protects against both focal and global brain ischemia,” Circulation, vol. 111, no. 7, pp. 913–919, 2005. View at Publisher · View at Google Scholar · View at Scopus
  68. Y. C. Chang and C. C. Huang, “Perinatal brain injury and regulation of transcription,” Current Opinion in Neurology, vol. 19, no. 2, pp. 141–147, 2006. View at Publisher · View at Google Scholar · View at Scopus
  69. J. E. Carroll, D. C. Hess, E. F. Howard, and W. D. Hill, “Is nuclear factor-κB a good treatment target in brain ischemia/reperfusion injury?” NeuroReport, vol. 11, no. 9, pp. R1–R4, 2000. View at Google Scholar · View at Scopus
  70. H. E. de Vries, J. Kuiper, A. G. de Boer, T. J. C. van Berkel, and D. D. Breimer, “The blood-brain barrier in neuroinflammatory diseases,” Pharmacological Reviews, vol. 49, no. 2, pp. 143–156, 1997. View at Google Scholar · View at Scopus
  71. J. Cao, J. I. Viholainen, C. Dart, H. K. Warwick, M. L. Leyland, and M. J. Courtney, “The PSD95-nNOS interface: a target for inhibition of excitotoxic p38 stress-activated protein kinase activation and cell death,” Journal of Cell Biology, vol. 168, no. 1, pp. 117–126, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. T. C. Nichols, “NF-κB and reperfusion injury,” Drug News and Perspectives, vol. 17, no. 2, pp. 99–104, 2004. View at Publisher · View at Google Scholar · View at Scopus
  73. M. S. Hayden and S. Ghosh, “Signaling to NF-κB,” Genes and Development, vol. 18, no. 18, pp. 2195–2224, 2004. View at Publisher · View at Google Scholar · View at Scopus